Advisory Board on Socio-Medical Affairs
The Advisory Board is tasked with analysing medical questions related to the health insurance system.
It is appointed by the Board of Directors of the Social Insurance Institution for a period of three years. The current term of the Advisory Board is 1 March 2022 - 28 February 2025.
Chair
Janne Leinonen, Chief Medical Director, Kela (neurology)
Deputy Chair and Member
Marjo Parkkila-Harju, Medical Director, Kela (general practice)
Secretary and Member
Katariina Kallio-Laine Senior Medical Advisor, Kela (neurology)
Members
- Eva Helaskoski, Chief Physician, Finnish Institute of Occupational Health (occupational healthcare)
- Markus Henriksson, Director General, National Supervisory Authority for Welfare and Health (supervisory affairs)
- Margareeta Häkkinen, Chief Physician, National Institute for Health and Welfare (healthcare, addiction medicine)
- Esa Jämsen, Professor, University of Helsinki, Faculty of Medicine (geriatrics)
- Erika Jääskeläinen, Adjunct Professor, University, Faculty of Medicine (psychiatry)
- Satu Lahti, Professor, University of Turku, Faculty of Medicine, Institute of Dentistry (community dentistry, healthcare)
- Eija Lönnroos, Professor, University of Eastern Finland, Faculty of Health Sciences, School of Medicine (geriatrics)
- Heikki Pärnänen, Director, Finnish Medical Association (general practice)
- Markku Sumanen, Professor, University of Tampere, Faculty of Medicine and Health Technology (general practice)
- Miia Turpeinen, Hospital Director, The Wellbeing Services County of North Ostrobothnia and Oulu University (clinical pharmacology)
- Henna Virtomaa, Executive Director, Finnish Dental Association (dentistry)
- Pekka Ylöstalo, University of Oulu, Faculty of Medicine, Institute of Dentistry (clinical dentistry, periodontology and geriatric dentistry)
Experts
- Oskari Heikinheimo, Professor, Helsinki University Hospital and University of Helsinki (gynecology)
- Asko Järvinen, Chief Physician, Helsinki University Hospital (internal medicine, infections, clinical pharmacology)
- Helena Kastarinen, Medical Director, Kela (internal medicine, nephology)
- Katariina Klintrup, Senior Medical Advisor, Kela (oncology)
- Riitta Luoto, Medical Director, Kela Research (healthcare, occupational healthcare)
- Mika Mäkelä, Professor, Helsinki University Hospital (pediatrics, allergology)
- Pasi Nevalainen, Head of Department, Tampere University Hospital (internal medicine, endocrinology)
- Jarkko Pajarinen, Chief of Division, Helsinki University Hospital (surgery, orthopedics and traumatology)
- Reima Palonen, Director, The Pharmaceuticals Pricing Board/ Ministry of Social Affairs and Health
- Anne Rönneberg, Coordinator, Kela (implementation of drug reimbursement system)
- Jarmo Salo, Head of Department, Northern Ostrobothnia Hospital District (pediatrics)
- Raija Sipilä, Managing Editor, Finnish Medical Society Duodecim (healthcare)
- Tero Soukka, Head of Department, Turku University Hospital, Department of Oral and Maxillofacial Diseases (dentistry, oral and maxillofacial surgery)
- Liisa Suominen, Professor, University of Eastern Finland, Faculty of Health Sciences, Institute of Dentistry (dentistry, healthcare)
- Terhi Tapiainen, Professor, University of Oulu and Oulu University Hospital (pediatrics, infections)
- Aleksi Tornio, Assistant Professor, University of Turku (clinical pharmacology)
- Juho Wedenoja, Senior Medical Officer for Development (ophthalmology)
Section for Pharmaceutical Affairs
Chair
- Hospital Director Miia Turpeinen, The Wellbeing Service, County of North Ostrobothnia and Oulu University
Secretary
- Katariina Klintrup, Senior Medical Advisor, Kela
Members
- Asko Järvinen, Chief Physician, Helsinki University Hospital
- Helena Kastarinen, Medical Director, Kela
- Janne Leinonen, Chief Medical Director, Kela
- Eija Lönnroos, Professor, University of Eastern Finland
- Anne Rönneberg, Coordinator, Kela
- Jarmo Salo, Head of Department, Northern Ostrobothnia Hospital District
- Aleksi Tornio, Assistant Professor, University of Turku
- Maija Pihlajamäki, Senior Medical Advisor, Kela
- Anna-Kaisa Parkkila, Chief Assessment Physician, TAYS
- Juho Wedenoja, Senior Medical Officer for Development, Fimea